Here's how you can reach us...
  • Tel:
  • Email:

Custom piRNA Synthesis Services

Inquiry

CD Formulation offers leading custom piRNA synthesis services. Leveraging advanced technology platforms and a professional R&D team, we provide precise and reliable piRNA solutions to scientists and research institutions worldwide, helping you achieve groundbreaking progress in genomic research.

What is piRNA (Piwi-interacting RNA)?

piRNA are unique small non-coding RNAs, consisting of 26 to 31 nucleotides, that interact closely with Piwi proteins. They predominantly exist in the germ and stem cells of animals and are vital for these cells' growth and preservation. Their structure includes a 5' end with single phosphate uracil and a 3' end with 2'-O-methylation, showcasing specific expression patterns in tissues. Biologically, piRNA play essential roles in gene silencing, the upkeep of germline and stem cell functions, as well as the regulation of protein synthesis and mRNA stability, thus being pivotal in maintaining genome stability and aiding in cell differentiation.

Functions of piRNA

  • Gene Silencing

piRNAs are small RNA molecules that play a key role in silencing genes within eukaryotic cells, especially crucial in inhibiting transposons.

  • Transposon Control

piRNAs, through their association with Piwi proteins, can locate and dismantle transposon RNAs, preventing the instability these elements might introduce into the genome.

  • Epigenetic Modulation

They contribute to changes in epigenetics by influencing the patterns of DNA methylation and the modification of histones.

  • Genome Stability

By attaching to repetitive DNA sequences, piRNAs help preserve the structural consistency of the genome.

Explore Our Custom piRNA Services

Solid Phase Synthesis Technology for piRNA

Solid phase synthesis technology is used for piRNA preparation by sequentially constructing the nucleotide chain on a solid support for efficient and accurate synthesis. Initially, the first nucleotide is attached via its 3' end to the solid support, securing it for subsequent reactions. Then, deprotection and coupling reactions are performed sequentially, using activators to add new nucleotides to the 5' end of the growing chain, maintaining precise chemical control to ensure sequence integrity. After completing the assembly of all nucleotides, protective groups are removed, and the piRNA is cleaved from the support and purified by HPLC to remove impurities, resulting in high-quality piRNA for research and application.

piRNA Analysis and Characterization

Items Descriptions
Sequence Analysis Sequencing technology allows extensive sequence analysis of piRNA, helping reveal its sequence characteristics, length distribution, and base preference.
Expression Profiling By comparing piRNA expression profiles under different conditions, scientists can further understand the functions and mechanisms of piRNA in various biological processes.
Structural Analysis Using bioinformatics tools to analyze the secondary structure of piRNA and its interaction pattern with Piwi proteins provides more background information for functional studies.

Considerations for Customizing piRNA

  • Ensure precise target sequence design, utilizing bioinformatics tools to predict potential off-target effects.
  • Choose high-purity reagents, especially key in coupling and modification steps, to improve synthesis success rate.
  • Adjust conditions like temperature, pH, and ionic strength as necessary to optimize reaction efficiency.
  • Employ appropriate purification techniques such as HPLC to ensure product purity and homogeneity.
  • In functional testing, evaluate the binding capability of piRNA to targets and its activity in cell models.

Our Technology Platforms

Platforms Descriptions
Solid Phase Synthesis Technology Platform This technology, through the incremental addition of nucleotides to a solid support, achieves high precision and purity in piRNA synthesis, suitable for large-scale production.
Sequencing Technology Platform Sequencing technology is used to verify the sequence accuracy of the synthesized piRNA, ensuring each nucleotide is in the correct position.
MS Platform Mass spectrometry is used to confirm the molecular weight and purity of piRNA, checking the accuracy and completeness of the synthesis process.
HPLC Platform HPLC aids in separating and purifying the synthesized piRNA samples, eliminating impurities and incomplete products.

General Workflow for piRNA Preparation

Fig.1 Flowchart of piRNA PreparationFig.1 Flow chart of piRNA preparation. (CD Formulation)

  • Target Identification and Design

Conduct a thorough analysis of the target genomic area using bioinformatics tools to design piRNA sequences capable of precise target binding, ensuring specificity and efficacy in subsequent experiments.

  • Sequence Synthesis

Employ the latest nucleic acid synthesis technology in the laboratory to synthesize the designed piRNA sequences and perform appropriate chemical and structural optimization based on preliminary experiments to enhance stability and bioactivity.

  • Validation and Modification

Synthesized piRNA needs to undergo biological function validation to ensure its efficacy in cells or model systems.

  • Production and Quality Control

Large-scale production of piRNA is based on a comprehensive quality control system to ensure batch consistency and product safety.

Our Advantages of piRNA Preparation Services

  • We deliver an all-inclusive suite of services, from preparing samples to analyzing data, guaranteeing our clients a streamlined and effortless experience.
  • Our adept bioinformatics team ensures precise and reliable data insights.
  • With state-of-the-art techniques, we maximize piRNA enrichment, surpassing typical market data yields.
  • By continually innovating technology and refining processes, we enhance synthesis efficacy and data integrity, strongly supporting clients' research endeavors.

Publication Data

Technology: Bioinformatics analysis of piRNA

Journal: bioRxiv

IF: -

Published: 2020

Results:

In studies on P. rockii fucata, researchers have explored the roles of piRNA beyond its known function of transposon suppression in animals. By using a specialized oligonucleotide (LNA-antagonist) to inhibit a specific piRNA, piRNA0001, they observed significant changes in the expression of numerous genes. Analysis predicted that piRNA0001 interacts with various genes, with several showing altered expression levels-some increased and others decreased. Furthermore, bioinformatics revealed that piRNA populations engage in the ping-pong cycle in a manner specific to tissue type.

Fig.2 piRNA Generation in P. fucataFig.2 piRNA biogenesis in P. fucata. (Huang S, et al., 2020)

At CD Formulation, we pride ourselves on delivering top-tier custom piRNA synthesis services that support your pioneering research in genomic science. Our advanced platforms and dedicated team ensure precision and excellence at every step. For bespoke solutions and to discuss your specific project needs, please get in touch with us.

References

  1. Huang S, Ichikawa Y, Yoshitake K, et al. Potential silencing of gene expression by PIWI-interacting RNAs (piRNAs) in somatic tissues in mollusk. bioRxiv. 2020: 2020.07. 12.199877.
How It Works
STEP 2
We'll email you to provide your quote and confirm order details if applicable.
STEP 3
Execute the project with real-time communication, and deliver the final report promptly.
Related Services

At CD Formulation, we understand the unique challenges and opportunities associated with nucleic acid formulation development. Our team of experts is dedicated to providing tailored solutions...

Learn More

  • Tel:
  • Email:

Stay up to date with our latest releases of new research and promotions.

Copyright © CD Formulation. All Rights Reserved.   Privacy Policy  Cookie Policy